Molecular Therapeutics
Ann Arbor
About Molecular Therapeutics
Molecular Therapeutics, Inc. (MRx) is a privately held biotechnology holding company that focuses on in-licensing promising pharmaceutical and medical device technologies in the late preclinical development phase and conducts proof-of-principle clinical (phase II) studies on a virtual basis for eventual corporate partnership and commercialization.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Website: moleculartherapeutics.com
- Phone: (734)259-4574
Industries & Categories
Biotechnology
Canonical: https://fsome.com/organization/molecular-therapeutics-2318536 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.